ENTITY

Merus NV (MRUS US)

8
Analysis
Health Care • Netherlands
Merus N.V. operates as a clinical-stage immuno-oncology company. The Company focuses on developing bispecific antibody therapeutics. Merus develops and manufactures therapeutics to treat and cure cancer patients.
more
Company Event • 21 Mar 2026 05:00 • Upcoming
Add To Calendar

Q4 2025

Company Event • 31 Oct 2025 22:00 • Upcoming
Add To Calendar

Corporate Presentation

Company Event • 31 Oct 2025 20:00 • Upcoming
Add To Calendar

Proxy Filing

Company Event • 31 Oct 2025 19:00 • Upcoming
Add To Calendar

Q3 2025

Company Event • 14 Aug 2025 01:30 • Latest

Canaccord Genuity’s 45th Annual Growth Conference

x